rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Nexavar

Rediff.com  »  News  »   Nexavar

  News for Nexavar

  • Business

Bayer to appeal against patent order on Nexavar

Bayer AG has said it will approach the high court in Mumbai against a ruling by Intellectual Property Appellate Board that upheld the compulsory licence issued to India's Natco Pharma to make and......

Sensex, Nifty underperform global indices; services PMI disappoint

Investors indulged in profit booking at attractive and higher valuations Markets finished the Friday session on a flat note as profit booking emerged following a private survey which indicated......

India's FDI during Apr-Feb jumps to $37.53 billion

Services attracted the most FDI during the first eleven months period of 2015-16. Foreign direct investment (FDI) in India increased to $37.53 billion during April-February period of the last......

GE, Boeing, Honeywell back India on patents

India’s IPR framework and enforcement were comparable to those in developed countries Large multinationals like General Electric (GE), Boeing and Honeywell have endorsed India’s......

India defends right to issue drug 'compulsory licences'

The USTR has placed India on its "priority watch" list for two years in a row, saying the country's patent laws unfairly favour local drug makers.     India has defended its right to......
  Web results for Nexavar
Bayer\\'s Stivarga Patent Challenged in Inter Partes Review

SAN FRANCISCO , July 27, 2016 /PRNewswire/ --Fustibal LLC (Fustibal), a targeted therapeutics biotechnology startup, today announced that it has... ...

http://www.asianhhm.com/prnews/bayer-s-stivarga-patent-challenged-in-inter-partes-review
Syndax Appoints Leading Experts to Scientific Advisory Board (SAB)

GlobeNewswire 2016-07-27 WALTHAM, Mass., July 27, 2016 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX), a clinical stage... ...

http://www.bizwireexpress.com/showstoryGNW.php?storyid=128760
Kidney Cancer Drugs Market Propelled by New Treatment Approvals

Transparency Market Research Report Added "Kidney Cancer Drugs Market - Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020"... ...

http://pressreleaseping.com/kidney-cancer-drugs-market-propelled-new-treatment-approvals
Phase III Data Show Bayers Stivarga regorafenib Improved Overall Survival in Previously Treated Patients with Unresectable Liver Cancer

Phase III Data Show Bayer\\'s Stivarga® (regorafenib) Improved Overall Survival in Previously Treated Patients with Unresectable Liver Cancer... ...

http://www.pharmafocusasia.com/pressreleases/phase-iii-data-show-bayer-s-stivarga-regorafenib-improved-overall-survival-in-previously-treated-patients-with-unresectable-liver-cancer
Natco Pharma up 8% on USFDA approval for cancer drug

Moneycontrol Bureau Share prices of Natco Pharma rose 8 percent intraday Thursday on the back of tentative approval received from USFDA for... ...

http://www.moneycontrol.com/news/buzzing-stocks/natco-pharma8usfda-approval-for-cancer-drug_6914961.html

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z